Zanubrutinib, lenalidomide and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as initial treatment in non–germinal center B-cell diffuse large B-cell lymphoma: a multi-center phase 2 study by Jiangsu Cooperative Lymphoma Group (JCLG) - Xia, Yi; Miao, Yi; Qian, Siqi; Zhang, Run; Qin, Shuchao; Xie, Xiaoyan; Li, Bingzong; Sha, Yeqin; Tang, Hanning; Jin, Hui; Cao, Lei; Xu, Wei; et al. (BMC Medicine, 2025)